We found no evidence that diagnosis of immune-related conditions ≥12 or ≥24 months prior to the date of cancer diagnosis was associated with risk of brain cancer overall; however, the brain cancer associations with IL-15 and IL-16 varied significantly by history of diagnosis of immune condition and were more pronounced in individuals with positive than negative history. The gene discussed is IL15; the disease is brain cancer.